Skip to main content

Table 2 Comparison of the differences between groups

From: Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial

 

Telemedicine group

Control group

P value

 

Baseline

(n = 212)

3 Month

(n = 136)

6 Month

(n = 115)

P

Baseline

(n = 206)

3 Month

(n = 101)

6 Month

(n = 65)

P

3 Month

6 Month

FBG (mmol/L)

7.12 ± 1.6

6.81 ± 0.9

6.93 ± 1.2

0.23

7.05 ± 1.6

6.91 ± 0.8

7.13 ± 1.1

0.65

0.45

0.32

HbA1c (%)

7.95 ± 0.9

7.52 ± 0.9

7.38 ± 1.1

0.00*

8.03 ± 0.9

7.77 ± 1.1

7.98 ± 0.1

0.38

0.11

0.00*

LBGI

2.62 ± 1.8

 

2.12 ± 0.9

0.03*

2.71 ± 1.2

 

2.52 ± 1.1

0.22

 

0.04*

DSMQ (sum scale)

6.75 ± 1.8

 

7.79 ± 1.2

0.00*

6.13 ± 1.9

 

6.76 ± 1.2

0.58

 

0.00*

BMI (Kg/m2)

24.61 ± 1.9

23.64 ± 1.3

23.17 ± 0.8

0.17

24.22 ± 1.5

24.35 ± 2.2

24.98 ± 0.6

0.44

0.42

0.21

Systolic BP (mmHg)

125.42 ± 13.3

123.25 ± 11.1

124.68 ± 9.8

0.90

125.51 ± 13.9

127.94 ± 12.5

124.17 ± 8.6

0.79

0.21

0.63

Diastolic BP (mmHg)

76.61 ± 9.1

74.94 ± 8.5

75.67 ± 6.3

0.73

77.17 ± 10.8

76.12 ± 12.3

75.8 ± 7.6

0.67

0.35

0.88

Triglycerides (mmol/L)

2.52 ± 0.8

2.15 ± 0.7

1.78 ± 0.4

0.00*

2.61 ± 1.0

2.34 ± 0.9

2.47 ± 1.8

0.82

0.67

0.00*

Total cholesterol (mmol/L)

5.41 ± 0.7

5.24 ± 1.3

5.37 ± 0.8

0.66

5.52 ± 0.9

5.45 ± 1.1

5.38 ± 1.2

0.43

0.73

0.92

HDL cholesterol (mmol/L)

1.13 ± 0.4

1.26 ± 0.3

1.14 ± 0.9

0.99

1.12 ± 0.3

1.08 ± 0.6

0.96 ± 0.6

0.24

0.42

0.11

LDL cholesterol (mmol/L)

3.81 ± 0.7

3.65 ± 0.6

3.59 ± 1.1

0.34

3.73 ± 0.8

3.74 ± 0.9

3.68 ± 1.0

0.87

0.76

0.91

BGM testing frequency(times/month)

1.90 ± 0.3

9.84 ± 0.5

6.97 ± 0.6

0.01*

1.72 ± 0.6

6.58 ± 0.6

3.69 ± 0.6

0.04*

0.03*

0.01*

RIR in two weeks(%)

51

72

68

0.04*

55

61

58

0.68

0.01*

0.02*

Hypoglycemic episodes (%)

  

6(4.4)

   

5(4.9)

  

0.71

Emergency department visits (%)

  

5(3.6)

   

3(2.9)

  

0.86

  1. Data is means ± SD, median and interquartile range, or n (%). FBG, fasting blood glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RIR, readings in-range (70 to 180 mg/dl); RIR in two weeks: RIR in the first 2 weeks of testing and in the 2 weeks prior to the 3 month and in the 2 weeks prior to the 6 month visit
  2. *P<0.05